Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues

被引:0
|
作者
Falk Zakrzewski
Walter de Back
Martin Weigert
Torsten Wenke
Silke Zeugner
Robert Mantey
Christian Sperling
Katrin Friedrich
Ingo Roeder
Daniela Aust
Gustavo Baretton
Pia Hönscheid
机构
[1] University Hospital Carl Gustav Carus (UKD),Institute of Pathology
[2] TU Dresden,Institute for Medical Informatics and Biometry (IMB)
[3] Carl Gustav Carus Faculty of Medicine,Center for Information Services and High Performance Computing (ZIH)
[4] TU Dresden,National Center for Tumor Diseases (NCT)
[5] TU Dresden,undefined
[6] Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG),undefined
[7] Center for Systems Biology Dresden (CSBD),undefined
[8] ASGEN GmbH & Co. KG,undefined
[9] Partner Site Dresden,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The human epidermal growth factor receptor 2 (HER2) gene amplification status is a crucial marker for evaluating clinical therapies of breast or gastric cancer. We propose a deep learning-based pipeline for the detection, localization and classification of interphase nuclei depending on their HER2 gene amplification state in Fluorescence in situ hybridization (FISH) images. Our pipeline combines two RetinaNet-based object localization networks which are trained (1) to detect and classify interphase nuclei into distinct classes normal, low-grade and high-grade and (2) to detect and classify FISH signals into distinct classes HER2 or centromere of chromosome 17 (CEN17). By independently classifying each nucleus twice, the two-step pipeline provides both robustness and interpretability for the automated detection of the HER2 amplification status. The accuracy of our deep learning-based pipeline is on par with that of three pathologists and a set of 57 validation images containing several hundreds of nuclei are accurately classified. The automatic pipeline is a first step towards assisting pathologists in evaluating the HER2 status of tumors using FISH images, for analyzing FISH images in retrospective studies, and for optimizing the documentation of each tumor sample by automatically annotating and reporting of the HER2 gene amplification specificities.
引用
收藏
相关论文
共 50 条
  • [31] Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: Comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH)
    Kiyose, Shinichiro
    Igarashi, Hisaki
    Nagura, Kiyoko
    Kamo, Takaharu
    Kawane, Kazunori
    Mori, Hiroki
    Ozawa, Takachika
    Maeda, Matsuyoshi
    Konno, Keisuke
    Hoshino, Hideaki
    Konno, Hiroyuki
    Ogura, Hiroyuki
    Shinmura, Kazuya
    Hattori, Naohiko
    Sugimura, Haruhiko
    PATHOLOGY INTERNATIONAL, 2012, 62 (11) : 728 - 734
  • [32] Characteristics of HER2 Gene Amplification by Fluorescence In Situ Hybridization in Endometrial Serous Carcinoma Implications for Clinical HER2 Testing and Interpretation
    Buza, Natalia
    Hui, Pei
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (03) : 331 - 337
  • [33] Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization
    Liu, HL
    Gandour-Edwards, R
    Lara, PN
    White, RD
    LaSalle, JM
    CANCER JOURNAL, 2001, 7 (05): : 395 - 403
  • [34] HER2 status in invasive breast cancer: Immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization
    Shirsat, Hemlata S.
    Epari, Sridhar
    Shet, Tanuja
    Bagal, Rajani
    Hawaldar, Rohini
    Desai, Sangeeta B.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (02) : 175 - 179
  • [35] Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer
    Park, Kyeongmee
    Han, Sehwan
    Kim, Jung-Yeon
    Kim, Hyun-Jung
    Kwon, Ji Eun
    Gwak, Geumhee
    JOURNAL OF BREAST CANCER, 2011, 14 (04) : 276 - 282
  • [36] SILVER-ENHANCED IN SITU HYBRIDIZATION AS AN ALTERNATIVE TO FLUORESCENCE IN SITU HYBRIDIZATION FOR ASSAYING HER2 AMPLIFICATION IN CLINICAL BREAST CANCER
    Han, S.
    Kim, J. S.
    Gwak, G.
    Park, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 29 - 29
  • [37] HER-2/neu gene amplification status in prostatic cancer (PC) by fluorescence in-situ hybridization (FISH).
    Ross, JS
    Sheehan, CE
    HaynerBuchan, AM
    Ambros, RA
    Kallakury, BVS
    Kaufman, R
    Fisher, HAG
    Muraca, PJ
    LABORATORY INVESTIGATION, 1997, 76 (01) : 501 - 501
  • [38] STATISTICAL ANALYSIS OF 100 BREAST CANCER CASES WITH EVALUATION OF HER2/NEU STATUS IMMUNOHISTOCHEMISTRY CORRELATION WITH GENE AMPLIFICATION BY FLUORESCENCE IN SITU HYBRIDIZATION ASSAY
    Sivakami
    Kannan, Indhu
    Madhusudhanan
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (49): : 5298 - 5303
  • [39] Evaluation of HER2 Gene Amplification in Breast Cancer Using Nuclei Microarray in Situ Hybridization
    Jiang, Huiyong
    Bai, Xiaoyan
    Zhang, Cheng
    Zhang, Xuefeng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (05) : 5519 - 5527
  • [40] HER2 amplification: Correlation of chromogenic in situ hybridization (CISH) with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH)
    Wixom, CR
    Albers, EA
    Weidner, N
    LABORATORY INVESTIGATION, 2003, 83 (01) : 51A - 51A